Document ID: chunk:federal_register_of_legislation:F2021L01913:reg:9:p2
Version: federal_register_of_legislation:F2021L01913
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 9098–12289

defined in the Schedule 1 - Dictionary.
(d)          having trauma involving the thyroid gland within the 14 days before the clinical onset of thyrotoxicosis;
             Note: trauma involving the thyroid gland is defined in the Schedule 1 - Dictionary.
(e)          ingesting excess thyroid hormone in medication, dietary supplements or in food containing thyroid extracts within the 3 months before the clinical onset of thyrotoxicosis;
(12)      having iodine excess within the 3 months before the clinical worsening of hyperthyroidism or thyrotoxicosis;
             Note 1: Iodine excess may be due to consuming foods, dietary supplements or medications with a high content of iodine.
Note 2: iodine excess is defined in the Schedule 1 - Dictionary.
(13)      being administered an iodine-containing radiographic contrast agent within the 3 months before the clinical worsening of hyperthyroidism or thyrotoxicosis;
(14)      taking amiodarone for a continuous period of at least 2 weeks, within the 1 year before the clinical worsening of hyperthyroidism or thyrotoxicosis;
(15)      taking a drug from the specified list of drugs within the 3 months before the clinical worsening of hyperthyroidism or thyrotoxicosis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(16)      taking minocycline for at least the 6 months before the clinical worsening of hyperthyroidism or thyrotoxicosis;
(17)      taking a drug containing at least 10 milligrams of iodine daily for a continuous period of at least 4 weeks, within the 3 months before the clinical worsening of hyperthyroidism or thyrotoxicosis;
(18)      having a thyroid-stimulating, hormone-secreting pituitary adenoma at the time of the clinical worsening of hyperthyroidism or thyrotoxicosis;
(19)      having a chorionic gonadotrophin-secreting neoplasm at the time of the clinical worsening of hyperthyroidism or thyrotoxicosis;
Note: chorionic gonadotrophin-secreting neoplasm is defined in the Schedule 1 - Dictionary.
(20)      having a primary or metastatic neoplasm involving the thyroid gland at the time of the clinical worsening of hyperthyroidism or thyrotoxicosis;
(21)      for thyrotoxic crisis only, having an acute precipitating event within the 48 hours before that clinical worsening of hyperthyroidism or thyrotoxicosis;
            Note: acute precipitating event and thyrotoxic crisis are defined in the Schedule 1 - Dictionary.
(22)      for thyrotoxicosis only:
(a)           having struma ovarii at the time of the clinical worsening of thyrotoxicosis;
             Note: struma ovarii is defined in the Schedule 1 - Dictionary.
(b)          having metastatic thyroid carcinoma containing functional thyroid tissue at the time of the clinical worsening of thyrotoxicosis;
(c)          having a form of thyroiditis from the specified list of forms of thyroiditis at the time of the clinical worsening of thyrotoxicosis;
             Note: specified list of forms of thyroiditis is defined in the Schedule 1 - Dictionary.
(d)          having trauma involving the thyroid gland within the 14 days before the clinical worsening of thyrotoxicosis;
             Note: trauma involving